NWBO

SEC source: 0001104659-24-096354 · tm2423270-1_4seq1.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 967,065

Underlying: COMMON STOCK PAR VALUE $0.001 · 1,000,000 shares

Expires 2028-08-31

F1 · kind: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES

SEC source: 0001104659-24-088927 · tm2421584-1_4seq1.xml · derivative · entry 1

BOSCH MARNIX L · CIK 0001253933 · CHIEF TECHNICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,549,157

Underlying: COMMON STOCK PAR VALUE $0.001 · 3,000,000 shares

Expires 2030-07-02

F1 · kind: GIFT FROM DR. BOSCH TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES

SEC source: 0001104659-24-087304 · tm2421126-1_4seq1.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,967,065

Underlying: COMMON STOCK PAR VALUE $0.001 · 2,967,065 shares

Expires 2028-08-31

F1 · kind: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES

SEC source: 0001104659-24-084069 · tm2420472-1_4seq1.xml · derivative · entry 1

MALIK NAVID · CIK 0001629113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,339,393

Underlying: Common Stock · 657,895 shares

Expires 2028-05-28

SEC source: 0001104659-23-122940 · tm2331758d1_4seq1.xml · nonDerivative · entry 3

MALIK NAVID · CIK 0001629113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Dr. Malik sold a total of 570,000 shares solely to pay a tax obligation, and all proceeds are being used for such taxes.

SEC source: 0001104659-23-122940 · tm2331758d1_4seq1.xml · nonDerivative · entry 2

MALIK NAVID · CIK 0001629113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,000

F1 · kind: Dr. Malik sold a total of 570,000 shares solely to pay a tax obligation, and all proceeds are being used for such taxes.

SEC source: 0001104659-23-122940 · tm2331758d1_4seq1.xml · nonDerivative · entry 1

MALIK NAVID · CIK 0001629113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 445,000

F1 · kind: Dr. Malik sold a total of 570,000 shares solely to pay a tax obligation, and all proceeds are being used for such taxes.

SEC source: 0001104659-23-041927 · tm2311802-1_4seq1.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,967,065

Underlying: COMMON STOCK PAR VALUE $0.001 · 6,794,191 shares

Expires 2030-07-02

F1 · kind: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES

SEC source: 0001104659-23-042303 · tm2311932-1_4seq1.xml · nonDerivative · entry 1

BOSCH MARNIX L · CIK 0001253933 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,355

F1 · kind: On April 3, 2023, Dr. Bosch was issued 119,355 shares of the Company's common stock pursuant to his exercise of certain options that were awarded in 2017.

SEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 4

BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,761,256

Underlying: COMMON STOCK PAR VALUE $0.001 · 4,500,000 shares

Expires 2030-12-01

F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES.

SEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 3

BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,761,256

Underlying: COMMON STOCK PAR VALUE $0.001 · 4,500,000 shares

Expires 2030-12-01

F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES.

SEC source: 0001104659-22-124667 · tm2231996-1_4seq1.xml · nonDerivative · entry 1

JASINOWSKI JERRY J · CIK 0001204048 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,235

F1 · kind: On December 1, 2022, the Issuer and Mr. Jasinowski entered into a Subscription Agreement (the "Agreement"). Pursuant to the Agreement, Mr. Jasinowski purchased 28,235 shares of the Issuer's Series C Convertible Preferred Stock at a price per share of $21.25, for an aggregate purchase price of approximately $600,000.

SEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 2

BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,761,256

Underlying: COMMON STOCK PAR VALUE $0.001 · 3,000,000 shares

Expires 2030-12-01

F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES.

SEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,761,256

Underlying: COMMON STOCK PAR VALUE $0.001 · 4,900,000 shares

Expires 2028-05-28

F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES.

SEC source: 0001104659-21-005311 · tm213558d1_4.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.001 · 3,402,935 shares

Expires 2027-06-13

F1 · kind: Gift from Dr. Boynton for estate planning purposes.

SEC source: 0001104659-20-115717 · tm2022243d17_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,558,724

Underlying: Common Stock, par value $0.001 per share · 3,000,000 shares

Expires 2030-12-01

F1 · kind: These options are gifts from Ms. Powers for no consideration.

SEC source: 0001104659-20-080814 · tm2022243d14_4.xml · derivative · entry 2

Powers Linda F · CIK 0001289624 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,665,524

Underlying: Common Stock, par value $0.001 · 8,665,524 shares

Expires 2030-07-02

F2 · kind: These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.

SEC source: 0001104659-20-080814 · tm2022243d14_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,104,905

Underlying: Common Stock, par value $0.001 · 2,104,905 shares

Expires 2030-07-02

F1 · kind: These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.

SEC source: 0001104659-20-080813 · tm2022243d13_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,558,724

Underlying: Common Stock, par value $0.001 · 32,558,724 shares

Expires 2030-12-01

F1 · kind: These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.

SEC source: 0001104659-20-080812 · tm2022243d12_4.xml · derivative · entry 2

Goldman Leslie J. · CIK 0001742619 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,415,952

Underlying: Common Stock, par value $0.001 · 5,415,952 shares

Expires 2030-07-02

F2 · kind: These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.

SEC source: 0001104659-20-080812 · tm2022243d12_4.xml · derivative · entry 1

Goldman Leslie J. · CIK 0001742619 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,315,566

Underlying: Common Stock, par value $0.001 · 1,315,566 shares

Expires 2030-07-02

F1 · kind: These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.

SEC source: 0001104659-20-080811 · tm2022243d11_4.xml · derivative · entry 1

Goldman Leslie J. · CIK 0001742619 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,822,937

Underlying: Common Stock, par value $0.001 · 21,822,937 shares

Expires 2030-12-01

F1 · kind: These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.

SEC source: 0001104659-20-080809 · tm2022243d9_4.xml · derivative · entry 1

BOSCH MARNIX L · CIK 0001253933 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,630,726

Underlying: Common Stock, par value $0.001 · 16,630,726 shares

Expires 2030-12-01

F1 · kind: These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.

SEC source: 0001104659-20-080810 · tm2022243d10_4.xml · derivative · entry 2

BOSCH MARNIX L · CIK 0001253933 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,249,572

Underlying: Common Stock, par value $0.001 · 3,249,572 shares

Expires 2030-07-02

F2 · kind: These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.

SEC source: 0001104659-20-080810 · tm2022243d10_4.xml · derivative · entry 1

BOSCH MARNIX L · CIK 0001253933 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,549,157

Underlying: Common Stock, par value $0.001 · 7,549,157 shares

Expires 2030-07-02

F1 · kind: These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.

SEC source: 0001104659-20-080808 · tm2022243d8_4.xml · derivative · entry 2

BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,491,338

Underlying: Common Stock, par value $0.001 · 2,491,338 shares

Expires 2030-07-02

F2 · kind: These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.

SEC source: 0001104659-20-080808 · tm2022243d8_4.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 605,160

Underlying: Common Stock, par value $0.001 · 605,160 shares

Expires 2030-07-02

F1 · kind: These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.

SEC source: 0001104659-20-080807 · tm2022243d7_4.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,697,693

Underlying: Common Stock, par value $0.001 · 15,697,693 shares

Expires 2030-12-01

F1 · kind: These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.

SEC source: 0001104659-20-080806 · tm2023608d1_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,249,474

Underlying: Common Stock, par value $0.001 per share · 15,249,474 shares

Expires 2025-11-01

F1 · kind: These warrants were in partial consideration of Ms. Powers' loans of $5.4 million to the Company and forbearance on the repayment of those loans. These warrants were approved and publicly reported in 2018. However, the documents to implement and issue (grant) these warrants were not executed until now. The exercise price was determined with reference to the price per share paid by unrelated investors.

SEC source: 0001104659-20-055770 · tm2018427d1_4.xml · derivative · entry 2

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,411,760

Underlying: Common Stock, par value $0.001 · 29,411,760 shares

Expires 2023-05-01

F3 · kind: J is the transaction code for "other acquisitions". It covers the deemed issuance of replacement warrants.

F1 · price: This portion of existing warrants held by Ms. Powers was extended in consideration for suspension of these warrants making them unexercisable until Nov. 1, 2020, and for suspension of other warrants held by Ms. Powers making those unexercisable until Nov. 1, 2020 as well. These extended warrants will have an exercise period of 2-1/2 years after the suspension period.

F1 · derivative.expiration_date: This portion of existing warrants held by Ms. Powers was extended in consideration for suspension of these warrants making them unexercisable until Nov. 1, 2020, and for suspension of other warrants held by Ms. Powers making those unexercisable until Nov. 1, 2020 as well. These extended warrants will have an exercise period of 2-1/2 years after the suspension period.

SEC source: 0001104659-20-055770 · tm2018427d1_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.001 · 29,411,760 shares

Expires 2020-05-02

F2 · kind: Extension of an existing warrant is deemed to be a cancellation and re-issuance. H is the transaction code which covers cancellation of securities.

SEC source: 0001104659-20-011526 · tm206922-1_4.xml · nonDerivative · entry 1

JASINOWSKI JERRY J · CIK 0001204048 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,891,347

F1 · kind: On February 3, 2020, the Issuer and Mr. Jasinowski entered into a Stock Purchase Agreement (the "Agreement"). Pursuant to the Agreement, Mr. Jasinowski purchased 526,316 shares of the Issuer's Common Stock at a price per share of $0.19, for an aggregate purchase price of approximately $100,000.

SEC source: 0001144204-19-003609 · tv511975_4.xml · derivative · entry 3

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Sale by Toucan Capital Fund III, LP.

Disclosed balance after: 0

Underlying: Common Stock, par value $0.001 · 402,073 shares

Expires 2023-05-04

SEC source: 0001144204-19-003609 · tv511975_4.xml · nonDerivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Sale by Toucan Capital Fund III, LP.

Disclosed balance after: 0

F1 · shares: Toucan Capital Fund III, LP sold the 804,146 restricted shares of common stock that it owned, in preparation for the required dissolution due to the Toucan Fund reaching the end of its contractual term. The reporting person has management control as well as a partnership interest in the Toucan Fund.

SEC source: 0001144204-19-003609 · tv511975_4.xml · derivative · entry 4

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.001 · 1,779,320 shares

Expires 2023-05-04

SEC source: 0001144204-19-003609 · tv511975_4.xml · nonDerivative · entry 2

Powers Linda F · CIK 0001289624 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,411,760

F2 · shares: The reporting party sold shares of restricted common stock.

SEC source: 0001144204-18-031802 · tv495285_4.xml · derivative · entry 1

BLACK COFER · CIK 0001669037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,715,000

Underlying: Common Stock, par value $0.001 · 1,715,000 shares

Expires 2028-05-28

F1 · shares: These 1,715,000 Options were previously reported and were approved by shareholders at the Special Shareholder Meeting on April 27, 2018. Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances.

F2 · price: The exercise price of the Options is $0.23.

SEC source: 0001144204-18-031801 · tv495286_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,200,000

Underlying: Common Stock, par value $0.001 · 39,200,000 shares

Expires 2028-05-28

F1 · shares: 29,400,000 of these 39,200,000 Options were previously reported on Form 8-K on January 16, 2018, following Board approval. Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances.

F2 · price: The exercise price of the Options is $0.23.

SEC source: 0001144204-18-031800 · tv495284_4.xml · derivative · entry 1

BOYNTON ALTON L · CIK 0001253935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,270,000

Underlying: Common Stock, par value $0.001 · 4,900,000 shares

Expires 2028-05-28

F1 · shares: Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances.

F2 · price: The exercise price of the Options is $0.23.

SEC source: 0001144204-18-031797 · tv495289_4.xml · derivative · entry 1

JASINOWSKI JERRY J · CIK 0001204048 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,900,000

Underlying: Common Stock, par value $0.001 · 4,900,000 shares

Expires 2028-05-28

F1 · shares: These 4,900,000 Options were previously reported and were approved by shareholders at the Special Shareholder Meeting on April 27, 2018. Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances.

F2 · price: The exercise price of the Options is $0.23.

SEC source: 0001144204-18-031815 · tv495290_4.xml · derivative · entry 1

MALIK NAVID · CIK 0001629113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,065,000

Underlying: Common Stock, par value $0.001 · 9,065,000 shares

Expires 2028-05-28

F1 · shares: These 9,065,000 Options were previously reported and were approved by shareholders at the Special Shareholder Meeting on April 27, 2018. Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances.

F2 · price: The exercise price of the Options is $0.23.

SEC source: 0001144204-18-034675 · tv495291_4.xml · derivative · entry 1

Goldman Leslie J. · CIK 0001742619 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,500,000

Underlying: Common Stock, par value $0.001 · 24,500,000 shares

Expires 2028-05-28

F1 · shares: 19,600,000 of these 24,500,000 Options were previously reported on Form 8-K on January 16, 2018, following Board approval. Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances.

F2 · price: The exercise price of the Options is $0.23.

SEC source: 0001144204-18-016240 · tv489185_form4.xml · derivative · entry 2

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Class D-2 Warrants · 869,565 shares

Expires not disclosed

F1 · derivative.exercise_price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · valueOwnedAfter: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-016240 · tv489185_form4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Series B Preferred Stock · 173,913 shares

Expires not disclosed

F1 · derivative.exercise_price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · valueOwnedAfter: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-016504 · tv489355_4a.xml · derivative · entry 3

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 869,565

Underlying: Common Stock · 869,565 shares

Expires not disclosed

F2 · security: As disclosed in the original filing and in footnote 1, certain Class D-2 Warrants were issued in connection with the notes issuance. This amendment is filed to further indicate the amount of such warrants.

F1 · price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-016504 · tv489355_4a.xml · derivative · entry 2

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Class D-2 Warrants · 869,565 shares

Expires not disclosed

F1 · derivative.exercise_price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.underlying_shares: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · valueOwnedAfter: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-016504 · tv489355_4a.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Series B Preferred Stock · 173,913 shares

Expires not disclosed

F1 · derivative.exercise_price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · price: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · valueOwnedAfter: The reporting person made a new loan of $400,000 to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 10 Class D-2 Warrants, with the Warrants on half of the principal being due and issuable when the loan is provided, and the Warrants on half of the principal and all of the accrued interest being due on a proportional basis in the event of conversion of some or all of the Note. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-014763 · tv488530_4.xml · derivative · entry 3

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,695,652

Underlying: Common Stock · 8,695,652 shares

Expires not disclosed

F1 · price: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-014763 · tv488530_4.xml · derivative · entry 2

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Class D-2 Warrants · 8,695,652 shares

Expires not disclosed

F1 · derivative.exercise_price: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · reported_value: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · price: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.underlying_shares: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · valueOwnedAfter: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

SEC source: 0001144204-18-014763 · tv488530_4.xml · derivative · entry 1

Powers Linda F · CIK 0001289624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Series B Preferred Stock · 1,739,130 shares

Expires not disclosed

F1 · derivative.exercise_price: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · reported_value: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · price: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.expiration_date: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · derivative.underlying_shares: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.

F1 · valueOwnedAfter: The reporting person made a new loan of $4 million to the Company in the form of a note convertible into Series B Preferred Stock and Class D-2 Warrants. Approximately half of the Class D-2 Warrants are due and issuable when the loan is provided, and approximately half are due on a proportional basis in the event of conversion of some or all of the Note. The note bears interest at a rate of 10% per annum, and is repayable upon 15 days' notice from the holder (and no later than five years from the date of the Note). The conversion price is $2.30 for one share of Series B Preferred Stock and 5 Class D-2 Warrants. Each share of Series B Preferred Stock is convertible into 10 shares of common stock when such shares of common stock are authorized and available. The Class D-2 Warrants are not currently exercisable, will expire five years after they become exercisable and have an exercise price of $0.30.